Metabolic diseases are serious threats to public health and related to gut microbiota.
Probiotics, prebiotics, synbiotics, and postbiotics (PPSP) are powerful regulators of gut …

Allergic diseases have been a global problem over the past few decades. The effect of
allergic diseases on healthcare systems and society is generally remarkable and is …

The world has been facing an epidemic of undernutrition along with population explosion,
resulting in a need for increased food availability. The concept behind food security is to …

BACKGROUND: Probiotics have a beneficial effect on nonalcoholic fatty liver disease
(NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still …

The gut microbiota plays critical roles in development of obese-related metabolic diseases
such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and insulin …

Background Probiotics have beneficial effect on obesity related disorders in animal models.
Despite a large number of animal data, randomized placebo-controlled trials (RCT) …

Background Non-alcoholic fatty liver disease (NAFLD), recognized as the liver manifestation
of metabolic syndrome, is highly prevalent in the general population. Recent studies suggest …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic fatty liver disease
worldwide, particularly in obese and type 2 diabetic individuals. Currently, there are no …

Introduction Many clinical studies have proved the effectiveness of probiotics in metabolic
disorders associated with insulin resistance. However, the impact of probiotic therapy on …

The main treatments for patients with nonalcoholic fatty liver disease (NAFLD) are currently
based on lifestyle changes, including ponderal decrease and dietary management …